FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973703293> ?p ?o ?g. }

• W1973703293 endingPage "2429" @default.
• W1973703293 startingPage "2421" @default.
• W1973703293 abstract "Cathepsins are involved in a variety of physiological processes including antigen processing and presentation and extracellular matrix degradation. In the present study, we evaluated whether expression levels of cathepsins S and B and their inhibitors cystatins B and C are affected by multiple sclerosis (MS) disease state (relapse and remission) and therapies (interferon-β [IFN-β] and the glucocorticoid [GC] methylprednisolone), and whether they are associated with the IFN-β response phenotype. Real-time PCR was employed to compare RNA expression levels in peripheral blood leucocytes (PBLs) and ELISA to determine serum protein levels of MS patients and matched healthy individuals. Cathepsin S RNA was higher in MS patients in the relapse state compared to controls (by 74%, P = 3 × 10(-5), n = 30 versus n = 18) with a similar increase observed in serum (66%, P = 0.002, n = 18 versus n = 20). GC treatment reduced cathepsin S levels in PBL RNA (by 44%, P = 6 × 10(-6), n = 27) and serum proteins (by 27%, P = 1 × 10(-5), n = 26), reduced the serum protein levels of pro-cathepsin B (by 8%, P = 0.0007, n = 23), and in parallel increased the serum levels of their inhibitor cystatin C (by 82%, P = 8 × 10(-6), n = 26). IFN-β therapy significantly elevated the RNA levels (n = 16) of cathepsin B (by 16%, P = 0.03), cystatin B (44%, P = 0.004) and cystatin C (48%, P = 0.011). In the serum, only cathepsin S levels were reduced by IFN-β (16%, P = 0.006, n = 25). Interestingly, pre-treatment serum cathepsin S/cystatin C ratio was higher in 'good responders' to IFN-β therapy compared to patients without a good response (by 94%, P = 0.003). These results suggest that cathepsin S and cystatin C may contribute to disease activity in MS, specifically in a subgroup of patients that are responsive to IFN-β therapy, and that these proteins should be further evaluated as biomarkers in MS." @default.
• W1973703293 created "2016-06-24" @default.
• W1973703293 creator A5017727550 @default.
• W1973703293 creator A5025413631 @default.
• W1973703293 creator A5045035877 @default.
• W1973703293 creator A5046845514 @default.
• W1973703293 creator A5083168810 @default.
• W1973703293 creator A5089242114 @default.
• W1973703293 date "2011-10-24" @default.
• W1973703293 modified "2023-10-18" @default.
• W1973703293 title "Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis" @default.
• W1973703293 cites W1539142963 @default.
• W1973703293 cites W1964415617 @default.
• W1973703293 cites W1965736363 @default.
• W1973703293 cites W1965771018 @default.
• W1973703293 cites W1967099433 @default.
• W1973703293 cites W1969825745 @default.
• W1973703293 cites W1980623675 @default.
• W1973703293 cites W1981290690 @default.
• W1973703293 cites W1983879753 @default.
• W1973703293 cites W1986346100 @default.
• W1973703293 cites W1991493131 @default.
• W1973703293 cites W1992692157 @default.
• W1973703293 cites W1996353122 @default.
• W1973703293 cites W2002174978 @default.
• W1973703293 cites W2008577620 @default.
• W1973703293 cites W2008755906 @default.
• W1973703293 cites W2012178046 @default.
• W1973703293 cites W2015871988 @default.
• W1973703293 cites W2020914781 @default.
• W1973703293 cites W2037345530 @default.
• W1973703293 cites W2045703917 @default.
• W1973703293 cites W2049644040 @default.
• W1973703293 cites W2049746643 @default.
• W1973703293 cites W2054462619 @default.
• W1973703293 cites W2055535173 @default.
• W1973703293 cites W2059193537 @default.
• W1973703293 cites W2060008832 @default.
• W1973703293 cites W2060862416 @default.
• W1973703293 cites W2062858578 @default.
• W1973703293 cites W2080700172 @default.
• W1973703293 cites W2082280250 @default.
• W1973703293 cites W2090968612 @default.
• W1973703293 cites W2093932892 @default.
• W1973703293 cites W2102698230 @default.
• W1973703293 cites W2104540904 @default.
• W1973703293 cites W2105490558 @default.
• W1973703293 cites W2107277218 @default.
• W1973703293 cites W2120203388 @default.
• W1973703293 cites W2124720965 @default.
• W1973703293 cites W2126537525 @default.
• W1973703293 cites W2130440034 @default.
• W1973703293 cites W2139673581 @default.
• W1973703293 cites W2142464285 @default.
• W1973703293 cites W2153764627 @default.
• W1973703293 cites W2154109740 @default.
• W1973703293 cites W2160423388 @default.
• W1973703293 cites W2160912425 @default.
• W1973703293 cites W2164238938 @default.
• W1973703293 cites W2170073367 @default.
• W1973703293 cites W2172169387 @default.
• W1973703293 cites W4211254511 @default.
• W1973703293 cites W4254397121 @default.
• W1973703293 doi "https://doi.org/10.1111/j.1582-4934.2010.01229.x" @default.
• W1973703293 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3822953" @default.
• W1973703293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21143385" @default.
• W1973703293 hasPublicationYear "2011" @default.
• W1973703293 type Work @default.
• W1973703293 sameAs 1973703293 @default.
• W1973703293 citedByCount "50" @default.
• W1973703293 countsByYear W19737032932013 @default.
• W1973703293 countsByYear W19737032932014 @default.
• W1973703293 countsByYear W19737032932015 @default.
• W1973703293 countsByYear W19737032932016 @default.
• W1973703293 countsByYear W19737032932017 @default.
• W1973703293 countsByYear W19737032932018 @default.
• W1973703293 countsByYear W19737032932019 @default.
• W1973703293 countsByYear W19737032932020 @default.
• W1973703293 countsByYear W19737032932021 @default.
• W1973703293 countsByYear W19737032932022 @default.
• W1973703293 countsByYear W19737032932023 @default.
• W1973703293 crossrefType "journal-article" @default.
• W1973703293 hasAuthorship W1973703293A5017727550 @default.
• W1973703293 hasAuthorship W1973703293A5025413631 @default.
• W1973703293 hasAuthorship W1973703293A5045035877 @default.
• W1973703293 hasAuthorship W1973703293A5046845514 @default.
• W1973703293 hasAuthorship W1973703293A5083168810 @default.
• W1973703293 hasAuthorship W1973703293A5089242114 @default.
• W1973703293 hasBestOaLocation W19737032931 @default.
• W1973703293 hasConcept C126322002 @default.
• W1973703293 hasConcept C134018914 @default.
• W1973703293 hasConcept C151701858 @default.
• W1973703293 hasConcept C153911025 @default.
• W1973703293 hasConcept C159641895 @default.
• W1973703293 hasConcept C167844969 @default.
• W1973703293 hasConcept C181199279 @default.
• W1973703293 hasConcept C185592680 @default.
• W1973703293 hasConcept C2779548226 @default.

• next